Oxidative and nitrative stress markers in glaucoma

Free Radical Biology and Medicine

Volumn 45, Issue 4, 2008, Pages 367-376

  Aslan, Mutay ^a   Cort, Aysegul ^a   Yucel, Iclal ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Glaucoma; Nitrative stress; Nitric oxide; Oxidative stress

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; CARBONYL DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OXYGEN RADICAL; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

CELL MEMBRANE; CILIARY BODY; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; ENZYME METABOLISM; GLAUCOMA; GLUCOSE OXIDATION; HUMAN; LIPID OXIDATION; LIPID PEROXIDATION; METHODOLOGY; NERVE DEGENERATION; NITRATION; NITRATIVE STRESS; NONHUMAN; OPTIC NERVE LESION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; UPREGULATION;

BIOLOGICAL MARKERS; GLAUCOMA; HUMANS; NITRATES; OXIDATIVE STRESS;

PRIMATES; RATTUS;

EID: 46649083004     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.04.026     Document Type: Review

References (115)

1. Fechtner R.D., and Weinreb R.N. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv. Ophthalmol. 39 (1994) 23-42
2. Yan D.B., Coloma F.M., Metheetrairut A., Trope G.E., Heathcote J.G., and Ethier C.R. Deformation of the lamina cribrosa by elevated intraocular pressure. Br. J. Ophthalmol. 78 (1994) 643-648
3. In: Salmon J.F., Glaucoma. Riordan-Eva P., Whitcher J.P., and Asbury T. (Eds). Vaughan & Asbury's General Ophthalmology 17th ed. Chapter 11 (2008), McGraw-Hill, New York p212-p222
4. Tripathi R.C., Chan W.F., Li J., and Tripathi B.J. Trabecular cells express the TGF-beta 2 gene and secrete the cytokine. Exp. Eye Res. 58 (1994) 523-528
5. Yun A.J., Murphy C.G., Polansky J.R., Newsome D.A., and Alvarado J.A. Proteins secreted by human trabecular cells. Glucocorticoid and other effects. Invest. Ophthalmol. Vis. Sci. 30 (1989) 2012-2022
6. Saccà S.C., Izzotti A., Rossi P., and Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp. Eye Res. 84 (2007) 389-399
7. Zhou L., Li Y., and Yue B.Y. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J. Cell. Physiol. 180 (1999) 182-189
8. Izzotti A. DNA damage and alterations of gene expression in chronic-degenerative diseases. Acta. Biochim. Pol. 50 (2003) 145-154
9. Sacca S.C., Pascotto A., Camicione P., Capris P., and Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch. Ophthalmol. 123 (2005) 458-463
10. Gottanka J., Johnson D.H., Martus P., and Lütjen-Drecoll E. Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork. J. Glaucoma 6 (1997) 123-133
11. Aslan M., Yucel I., Akar Y., Yucel G., Ciftcioglu M.A., and Sanlioglu S. Nitrotyrosine formation and apoptosis in rat models of ocular injury. Free Radic. Res. 40 (2006) 147-153
12. Liu B., and Neufeld A.H. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia 30 (2000) 178-186
13. Shareef S., Sawada A., and Neufeld A.H. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2884-2891
14. Neufeld A.H., Sawada A., and Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9944-9948
15. Sarih M., Souvannavong V., and Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 191 (1993) 503-508
16. Hu J., and Van Eldik L.J. S100 beta induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim. Biophys. Acta. 1313 (1996) 239-245
17. Heneka M.T., Loschmann P.A., Gleichmann M., Weller M., Schulz J.B., Wullner U., and Klockgether T. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J. Neurochem. 71 (1998) 88-94
18. Reed J.C. Mechanisms of apoptosis. Am. J. Pathol. 157 (2000) 1415-1430
19. Saeki K., Kobayashi N., Inazawa Y., Zhang H., Nishitoh H., Ichijo H., Saeki K., Isemura M., and You A. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem. J. 368 (2002) 705-720
20. Jun C.D., Oh C.D., Kwak H.J., Pae H.O., Yoo J.C., Choi B.M., Chun J.S., Park R.K., and Chung H.T. Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. J. Immunol. 162 (1999) 3395-3401
21. Hortelano S., Alvarez A.M., and Boscá L. Nitric oxide induces tyrosine nitration and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages. FASEB J. 13 (1999) 2311-2317
22. Kim Y.M., Bombeck C.A., and Billiar T.R. Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res. 84 (1999) 253-256
23. Chen F., Castranova V., Shi X., and Demers L.M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 45 (1999) 7-17
24. Peng H.B., Libby P., and Liao J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270 (1995) 14214-14219
25. Tezel G., Yang X., and Cai J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3177-3187
26. Ko M.L., Peng P.H., Ma M.C., Ritch R., and Chen C.F. Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic. Biol. Med. 39 (2005) 365-373
27. Choi J., Kim K.H., Jeong J., Cho H.S., Lee C.H., and Kook M.S. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest. Ophthalmol. Vis. Sci. 48 (2007) 104-111
28. Mozaffarieh M., Grieshaber M.C., and Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol. Vis. 14 (2008) 224-233
29. Henry T.D., Archer S.L., Nelson D., Weir E.K., and From A.H. Enhanced chemiluminescence as a measure of oxygen-derived free radical generation during ischemia and reperfusion. Circ. Res. 67 (1990) 1453-1461
30. Wallace D.C. Mitochondrial diseases in man and mouse. Science 283 (1999) 1482-1488
31. Andrews R.M., Griffiths P.G., Johnson M.A., and Turnbull D.M. Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br. J. Ophthalmol. 83 (1999) 231-235
32. Harada T., Harada C., Nakamura K., Quah H.M., Okumura A., Namekata K., Saeki T., Aihara M., Yoshida H., Mitani A., and Tanaka K. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J. Clin. Invest. 117 (2007) 1763-1770
33. Ritch R., and Schlotzer-Schrehardt U. Exfoliation syndrome. Surv. Ophthalmol. 45 (2001) 265-315
34. Ritch R., Schlotzer-Schrehardt U., and Konstas A.G. Why is glaucoma associated with exfoliation syndrome?. Prog. Retin. Eye Res. 22 (2003) 253-275
35. Freeman B.A., and Crapo J.D. Biology of disease: free radicals and tissue injury. Lab. Invest. 47 (1982) 412-426
36. Bergamini C.M., Gambetti S., Dondi A., and Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr. Pharm. Des. 10 (2004) 1611-1626
37. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605
38. Loschen G., Azzi A., Richter C., and Flohe L. Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Lett. 42 (1974) 68-72
39. Fantone J.C., and Ward P.A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol. 107 (1982) 395-418
40. Babior B.M., Lambeth J.D., and Nauseef W. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397 (2002) 342-344
41. Nikjoo H., O'Neill P., Terrissol M., and Goodhead D.T. Modelling of radiation-induced DNA damage: the early physical and chemical event. Int. J. Radiat. Biol. 66 (1994) 453-457
42. Spiteller G. Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products. Free Radic. Biol. Med. 41 (2006) 362-387
43. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
44. Kanner J., German J.B., and Kinsella J.E. Initiation of lipid peroxidation in biological systems. Crit. Rev. Food Sci. Nutr. 25 (1987) 317-364
45. Spiteller G. Do changes in the cell membrane structure induce the generation of lipid peroxidation products which serve as first signalling molecules in cell to cell communication?. Prostaglandins Leukot. Essent. Fat. Acids 67 (2002) 151-162
46. Hogg N., Kalyanaraman B., Joseph J., Struck A., and Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett. 334 (1993) 170-174
47. Lancaster Jr. J.R. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1 (1997) 18-30
48. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 (2001) 593-615
49. Park C.S., Pardhasaradhi K., Gianotti C., Villegas E., and Krishna G. Human retina expresses both constitutive and inducible isoforms of nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 205 (1994) 85-91
50. Chakravarthy U., Stitt A.W., McNally J., Bailie J.R., Hoey E.M., and Duprex P. Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr. Eye Res. 14 (1995) 285-294
51. Perez M.T., Larsson B., Alm P., Andersson K.E., and Ehinger B. Localisation of neuronal nitric oxide synthase-immunoreactivity in rat and rabbit retinas. Exp. Brain Res. 104 (1995) 207-217
52. Becquet F., Courtois Y., and Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv. Ophthalmol. 42 (1997) 71-82
53. Aslan M., Yucel I., Ciftcioglu A., Savas B., Akar Y., Yucel G., and Sanlioglu S. Corneal protein nitration in experimental uveitis. Exp. Biol. Med. (Maywood) 232 (2007) 1308-1313
54. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1620-1624
55. Rubbo H., Darley-Usmar V., and Freeman B.A. Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9 (1996) 809-820
56. Radi R., Denicola A., and Freeman B.A. Peroxynitrite reactions with carbon dioxide-bicarbonate. Methods Enzymol. 301 (1999) 353-367
57. Aslan M., and Freeman B.A. Redox-dependent impairment of vascular function in sickle cell disease. Free Radic. Biol. Med. 43 (2007) 1469-1483
58. Stadtman E.R., and Oliver C.N. Metal-catalyzed oxidation of proteins. Physiological consequences. J. Biol. Chem. 266 (1991) 2005-2008
59. Shacter E. Protein oxidative damage. Methods Enzymol. 319 (2000) 428-436
60. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233 (1994) 357-363
61. Stadtman E.R., and Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10 (1997) 485-494
62. Poli G., and Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50 (2000) 315-321
63. Poli G., Leonarduzzi G., Biasi F., and Chiarpotto E. Oxidative stress and cell signalling. Curr. Med. Chem. 11 (2004) 1163-1182
64. Yeo H.C., Helbock H.J., Chyu D.W., and Ames B.N. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal. Biochem. 220 (1994) 391-396
65. Pratico D. F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis 147 (1999) 1-10
66. Morrow J.D. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug. Metab. Rev. 32 (2000) 377-385
67. Blair I.A. DNA-adducts with lipid peroxidation products. J. Biol. Chem. (2008) Feb 19; [Electronic publication ahead of print]
68. Marnett L.J., Riggins J.N., and West J.D. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J. Clin. Invest 111 (2003) 583-593
69. Pollack M., Yang I.Y., Kim H.Y., Blair I.A., and Moriya M. Translesion DNA Synthesis across the heptanone-etheno-2′-deoxycytidine adduct in cells. Chem. Res. Toxicol. 19 (2006) 1074-1079
70. Brownlee M., Cerami A., and Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318 (1988) 1315-1321
71. Fu M.X., Wells-Knecht K.J., Blackledge J.A., Lyons T.J., Thorpe S.R., and Baynes J.W. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43 (1994) 676-683
72. Lapolla A., Traldi P., and Fedele D. Importance of measuring products of non-enzymatic glycation of proteins. Clin. Biochem. 38 (2005) 103-115
73. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat. Res. 275 (1992) 331-342
74. Shigenaga M.K., Aboujaoude E.N., Chen Q., and Ames B.N. Assays of oxidative DNA damage biomarkers 8-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 234 (1994) 16-33
75. Collins A.R., and Horvathova E. Oxidative DNA damage, antioxidants and DNA repair: applications of the comet assay. Biochem. Soc. Trans. 29 (2001) 337-341
76. Cassina A.M., Hodara R., Souza J.M., Thomson L., Castro L., Ischiropoulos H., Freeman B.A., and Radi R. Cytochrome c nitration by peroxynitrite. J. Biol. Chem. 275 (2000) 21409-21415
77. MacPherson J.C., Comhair S.A., Erzurum S.C., Klein D.F., Lipscomb M.F., Kavuru M.S., Samoszuk M.K., and Hazen S.L. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J. Immunol. 166 (2001) 5763-5772
78. Aslan M., Ryan T.M., Townes T.M., Coward L., Kirk M.C., Barnes S., Alexander C.B., Rosenfeld S.S., and Freeman B.A. Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J. Biol. Chem. 278 (2003) 4194-4204
79. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., and Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269 (1994) 26066-26075
80. Williamson K.S., Gabbita S.P., Mou S., West M., Pye Q.N., Markesbery W.R., Cooney R.V., Grammas P., Reimann-Philipp U., Floyd R.A., and Hensley K. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 6 (2002) 221-227
81. Lim D.G., Sweeney S., Bloodsworth A., White C.R., Chumley P.H., Krishna N.R., Schopfer F., O'Donnell V.B., Eiserich J.P., and Freeman B.A. Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15941-15946
82. Baker P.R., Schopfer F.J., Sweeney S., and Freeman B.A. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11577-11582
83. Yaǧci R., Gürel A., Ersöz I., Keskin U.C., Hepşen I.F., Duman S., and Yiǧitoǧlu R. Oxidative stress and protein oxidation in pseudoexfoliation syndrome. Curr. Eye Res. 31 (2006) 1029-1032
84. Olsen K.W., Moras D., and Rossmann M.G. Sequence variability and structure of D-glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 250 (1975) 9313-9321
85. Schmalhausen E.V., Nagradova N.K., Boschi-Muller S., Branlant G., and Muronetz V.I. Mildly oxidized GAPDH: the coupling of the dehydrogenase and acyl phosphatase activities. FEBS Lett. 452 (1999) 219-222
86. Danshina P.V., Schmalhausen E.V., Avetisyan A.V., and Muronetz V.I. Mildly oxidized glyceraldehyde-3-phosphate dehydrogenase as a possible regulator of glycolysis. IUBMB Life 51 (2001) 309-314
87. Lindquist S., and Craig E.A. The heat-shock proteins. Annu. Rev. Genet. 22 (1988) 631-677
88. Caprioli J., Kitano S., and Morgan J.E. Hyperthermia and hypoxia increase tolerance of retinal ganglion cells to anoxia and excitotoxicity. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2376-2381
89. Caprioli J., Ishii Y., and Kwong J.M. Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Trans. Am. Ophthalmol. Soc. 101 (2003) 39-50 discussion 50-31
90. Albrecht J., Sonnewald U., Waagepetersen H.S., and Schousboe A. Glutamine in the central nervous system: function and dysfunction. Front. Biosci. 12 (2007) 332-343
91. Linser P.J., Sorrentino M., and Moscona A.A. Cellular compartmentalization of carbonic anhydrase-C and glutamine synthetase in developing and mature mouse neural retina. Brain Res. 315 (1984) 65-71
92. Babizhayev M.A., and Bunin A. Lipid peroxidation in open-angle glaucoma. Acta. Ophthalmol. (Copenh). 67 (1989) 371-377
93. Gartaganis S.P., Patsoukis N.E., Nikolopoulos D.K., and Georgiou C.D. Evidence for oxidative stress in lens epithelial cells in pseudoexfoliation syndrome. Eye 21 (2007) 1406-1411
94. Koliakos G.G., Konstas A.G., Schlötzer-Schrehardt U., Hollo G., Katsimbris I.E., Georgiadis N., and Ritch R. 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br. J. Ophthalmol. 87 (2003) 353-356
95. Yucel I., Akar Y., Yucel G., Ciftcioglu M.A., Keles N., and Aslan M. Effect of hypercholesterolemia on inducible nitric oxide synthase expression in a rat model of elevated intraocular pressure. Vis. Res. 45 (2005) 1107-1114
96. Kruman I., Bruce-Keller A.J., Bredesen D., Waeg G., and Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17 (1997) 5089-5100
97. Malone P.E., and Hernandez M.R. 4-Hydroxynonenal, a product of oxidative stress, leads to an antioxidant response in optic nerve head astrocytes. Exp. Eye Res. 84 (2007) 444-454
98. Dickinson D.A., Levonen A.L., Moellering D.R., Arnold E.K., Zhang H., Darley-Usmar V.M., and Forman H.J. Human glutamate cysteine ligase gene regulation through the electrophile response element. Free Radic. Biol. Med. 37 (2004) 1152-1159
99. Dickinson D.A., Iles K.E., Watanabe N., Iwamoto T., Zhang H., Krzywanski D.M., and Forman H.J. 4-hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells. Free Radic. Biol. Med. 33 (2002) 974
100. Moreno M.C., Campanelli J., Sande P., Sanez D.A., Keller Sarmiento M.I., and Rosenstein R.E. Retinal oxidative stress induced by high intraocular pressure. Free Radic. Biol. Med. 37 (2004) 803-812
101. Bierhaus A., Hofmann M.A., Ziegler R., and Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc. Res. 37 (1998) 586-600
102. Tezel G., Luo C., and Yang X. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1201-1211
103. Zoric L., Miric D., Milenkovic S., Jovanovic P., and Trajkovic G. Pseudoexfoliation syndrome and its antioxidative protection deficiency as risk factors for age-related cataract. Eur. J. Ophthalmol. 16 (2006) 268-273
104. Yucel I., Yucel G., Akar Y., Demir N., Gurbuz N., and Aslan M. Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine. Can. J. Ophthalmol. 41 (2006) 60-66
105. Vasan S., Foiles P., and Founds H. Therapeutic potential of breakers of advanced glycation end product-protein crosslinks. Arch. Biochem. Biophys. 419 (2003) 89-96
106. Mannervik B., Alin P., Guthenberg C., Jensson H., Tahir M.K., Warholm M., and Jornvall H. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 7202-7206
107. Fridovich I. Superoxide dismutases. Adv. Enzymol. Relat. Areas Mol. Biol. 58 (1986) 61-97
108. Costarides A.P., Riley M.V., and Green K. Roles of catalase and the glutathione redox cycle in the regulation of anterior-chamber hydrogen peroxide. Ophthalmic Res. 23 (1991) 284-294
109. De La Paz M.A., and Epstein D.L. Effect of age on superoxide dismutase activity of human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1849-1853
110. Riley M.V. Physiologic neutralization mechanisms and the response of the corneal endothelium to hydrogen peroxide. Clao J. 16 (1990) S16-S21
111. Richer S.P., and Rose R.C. Water soluble antioxidants in mammalian aqueous humor: interaction with UV B and hydrogen peroxide. Vis. Res 38 (1998) 2881-2888
112. May J.M. Is ascorbic acid an antioxidant for the plasma membrane?. Faseb J. 13 (1999) 995-1006
113. Asregadoo E.R. Blood levels of thiamine and ascorbic acid in chronic open-angle glaucoma. Ann. Ophthalmol. 11 (1979) 1095-1100
114. Gherghel D., Griffiths H.R., Hilton E.J., Cunliffe I.A., and Hosking S.L. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 46 (2005) 877-883
115. Kang J.H., Pasquale L.R., Willett W., Rosner B., Egan K.M., Faberowski N., and Hankinson S.E. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am. J. Epidemiol. 158 (2003) 337-346